Buprenorphine And Naloxone Film
Product Images NDC 67296-1933

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-1933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12mg-3mg-carton (12mg 3mg Carton)

The text extracted provides information about Buprenorphine and Naloxone sublingual film, specifically a 12mg/3mg dosage. It contains instructions for pharmacists to dispense a Medication Guide to each patient and highlights the importance of keeping the medication out of children's reach due to potential emergency situations. Furthermore, it emphasizes not cutting, chewing, or swallowing the sublingual films and mentions the quantity of pouches containing one sublingual film each. The text also includes barcode numbers and specific drug instructions.*

FDA Label Image

12mg-3mg-pouch (12mg 3mg Pouch)

FDA Label Image

2mg-0pt5mg-carton (2mg 0pt5mg Carton)

This is a detailed instruction leaflet for Buprenorphine and Naloxone Sublingual Film, emphasizing the importance of keeping the medication out of the reach of children to prevent accidental ingestion. It provides guidance for use, advises against cutting or swallowing the film, and highlights the need for emergency medical care if a child accidentally takes the medication. Additionally, it includes dosing information and instructions for the pharmacist to dispense the Medication Guide to each patient.*

FDA Label Image

2mg-0pt5mg-pouch (2mg 0pt5mg Pouch)

FDA Label Image

4mg-1mg-carton (4mg 1mg Carton)

FDA Label Image

4mg-1mg-pouch (4mg 1mg Pouch)

FDA Label Image

8mg-2mg-carton (8mg 2mg Carton)

This is a description of a medication called Buprenorphine and Naloxone Sublingual Film. The film is prescribed in doses of 8 mg/2 and is intended for sublingual administration. Patients are advised not to cut, chew, or swallow the film. It also includes a warning about the necessity of keeping the medication out of reach of children, as accidental ingestion may require emergency medical attention. Pharmacies are instructed to dispense a Medication Guide to each patient.*

FDA Label Image

8mg-2mg-pouch (8mg 2mg Pouch)

FDA Label Image

Figure-1 (Figure 1)

FDA Label Image

Figure-2 (Figure 2)

FDA Label Image

Figure-3 (Figure 3)

FDA Label Image

Structure-buprenorphine (Structure Buprenorphine)

FDA Label Image

Structure-naloxone (Structure Naloxone)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.